Growth Opportunities in Protein Expression Market Protein Expression | Página 2

The therapeutic applications segment is expected to dominate the market in 2017
By application, the protein expression market is segmented into therapeutic applications,
research applications and industrial applications.The therapeutic applications segment holds
the largest share in the market; however, the research applications segment is expected to
grow at the highest growth rate during the forecast period. Growth in the research applications
segment is primarily attributed to the increase in proteomics-based research activities around
the world.
By end user, the pharmaceutical and biotechnology companies segment is expected to hold
the largest share of the market in 2017
On the basis of end users, the protein expression market is segmented into academic research
institutes; contract research organizations (CROs); pharmaceutical and biotechnology
companies; and other end users (food processing industry, detergent manufacturers, paper
industry, leather industry, breweries, dairy industry, chemical industry, bioplastic industry, and
cosmeceutical industry).The pharmaceutical and biotechnology companies segment holds the
largest share in the market; however, the CROs segment is expected to grow at the highest
growth rate during the forecast period.
Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924
Asia offers lucrative growth opportunities
By region, the global protein expression market is segmented into North America, Europe, Asia,
and the Rest of the World (RoW). While North America holds the largest share of the market in
2016, Asia is expected to grow at the highest CAGR during the forecast period. The presence of
emerging economies like China and India; the large population and rising prevalence of chronic
diseases in these countries; a growing demand of biologics; and the improving life sciences
research infrastructure are the major factors driving the growth of this regional segment.
Key players operating in the protein expression market include Merck KGaA (Germany), Thermo
Fisher Scientific Inc. (U.S.), Becton, Dickinson & Company (U.S.), Agilent Technologies, Inc.
(U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), Lonza Group Ltd. (Switzerland), Bio-
Rad Laboratories, Inc. (U.S.), GenScript Biotech Corporation (China), Lucigen Corporation (U.S.),
Synthetic Genomics Inc. (U.S.), Promega Corporation (U.S.), New England Biolabs, Inc. (U.S.),
Sengenics (Singapore.), ARTES Biotechnology GmbH (Germany), Addgene Inc. (U.S.) ,
LifeSensors Inc. (U.S.), Accelagen Inc. (U.S.), Geneva Biotech (Switzerland), Viva Biotech (China),
Profacgen (U.S.), ProteoGenix (France), Peak Proteins Ltd. (U.K.), Domainex Ltd. (U.K.), and Jena
Bioscience GmbH (Germany).
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies